Coccidioidomycosis
3
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
3
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
2100%
+ 2 programs with unclassified modality
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Allergy TherapeuticsUK - West Sussex
1 programPathogenesis and Genetics of Disseminated or Refractory CoccidioidomycosisN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
Sharp TherapeuticsPosaconazole
Nielsen BioSciencesSpherule-derived coccidioidin
Allergy TherapeuticsPathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Clinical Trials (3)
Total enrollment: 529 patients across 3 trials
POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)
Start: May 2007Est. completion: May 200916 patients
Phase 3Completed
A Multi-center Study of Spherule-Derived Coccidioidin
Start: May 2005Est. completion: Sep 2007113 patients
Phase 3Completed
NCT02190266Allergy TherapeuticsPathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Pathogenesis and Genetics of Disseminated or Refractory Coccidioidomycosis
Start: Sep 2014Est. completion: Jul 2029400 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 529 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.